Andrew Dudum, CEO of Hims & Hers Health, Inc., executed a stock option to acquire 33,668 shares of Class A Common Stock at $2.43 per share on January 16, 2025. On the same day, Mr. Dudum sold a total of 77,960 shares of Class A Common Stock at prices ranging from $26.70 to $28.105 per share. These transactions were conducted under a Rule 10b5-1 trading plan adopted on August 28, 2024. Following these transactions, Mr. Dudum directly owns 27,918 shares and indirectly owns a total of 9,703,113 shares through various trusts. The indirect holdings include shares held by the Dudum Family Community Property Trust, Andrew Dudum 2015 Trust, and several GRATs (Grantor Retained Annuity Trusts).